APx Acquisition Corp. I
APXIU
NASDAQ Global Market11.55
USD
-0.28
- -
APx Acquisition Corp. I
APXIU
(NASDAQ Global Market)
Recent
price
11.55
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- APx Acquisition Corp. I (NASDAQ:APXIU) operates as a blank check company, or special purpose acquisition company (SPAC), formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities; it offers no current products or services beyond this structure, generating no significant operations or revenue while holding funds in trust for deployment post-combination. The company, founded in 2021 and headquartered at Juan Salvador Agraz 65 Contadero, Cuajimalpa de Morelos, Mexico City, Mexico, focuses primarily on targets in Spanish-speaking Latin America, Mexico, and Hispanic firms in the United States, with operations spanning North America and potential expansion into targeted merger regions. Recent major changes include the extension of its business combination deadline to December 9, 2025, approved at an extraordinary general meeting with significant share redemptions totaling approximately $60.86 million; issuance of promissory notes worth $700,000 and $446,000 at 20% interest to Bioceres LLC, tied to its ongoing pursuit of a merger with OmnigenicsAI Corp., a precision medicine firm; termination of a prior business combination agreement with MultiplAI Health Ltd due to regulatory risks and operational mismatches; and impending delisting of its warrants from NASDAQ for failing minimum market value requirements while maintaining Class A ordinary share listings.